(NASDAQ: AMIX) ("Autonomix” or the "Company”), a medical device company focused on advancing precision nerve-targeted treatments, today highlighted positive preliminary results from the first five ...
Promising Preclinical Results Position Ketamir-2 as a Potential Breakthrough Therapy That Surpasses Current Treatments, With Results to Be Presented at the Pain Therapeutics Summit in Boston MIAMI, FL ...
And take the prescribed medication, of course. But little else need be taught them to do ... The individual given this diagnosis isn’t told about the consequences of diabetes to the feet, especially ...